NCT04775134View on ClinicalTrials.gov

Residual SARS-CoV-2 Presence in the Respiratory Tract and Lung Parenchyma (After SARS-CoV-2 Infection or COVID-19)

RecruitingOBSERVATIONAL

Enrollment

75

Participants

Timeline

Start Date

January 31, 2021

Primary Completion Date

May 31, 2025

Study Completion Date

December 31, 2025

Conditions

Covid19

Interventions

DIAGNOSTIC_TEST

Lung biopsy

Biopsy of residuary material from a medically indicated pulmonary resection

Trial Locations (1)

3000

RECRUITING

UZ Leuven, Leuven

All Listed Sponsors

lead

Universitaire Ziekenhuizen KU Leuven

OTHER